By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Oncolytics Biotech Inc. 

210-1167 Kensington Crescent

Calgary  Alberta  T2N 1X7  Canada
Phone: 403-670-7374 Fax: 403-283-0858


SEARCH JOBS


Industry
Biotechnology






Company News
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN Preclinical Data At The 2015 AACR Annual Meeting 4/20/2015 10:34:38 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Malignant Gliomas 4/17/2015 6:25:59 AM
Oncolytics Biotech Inc. (ONC.TO) Presents At UK Immuno-Oncology Meeting 4/15/2015 2:24:22 PM
Media Advisory - Oncolytics Biotech Inc. (ONC.TO) To Participate In The 14th Annual Needham Healthcare Conference 4/13/2015 7:24:41 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Filing For Orphan Drug Designation With The U.S. FDA For Gastric Cancer 4/7/2015 6:26:31 AM
Oncolytics Biotech Inc. (ONC.TO) Presents At The 2015 Immune Checkpoint Inhibitors Meeting 3/26/2015 1:17:57 PM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Status From The European Medicines Agency For Ovarian Cancer 3/25/2015 6:22:39 AM
Oncolytics Biotech Inc. (ONC.TO) Announces 2014 Year End Results 3/17/2015 10:31:06 AM
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015 9:26:46 AM
Oncolytics Biotech Inc. (ONC.TO) Announces Receipt Of Orphan Drug Designation From The U.S. FDA For Primary Peritoneal Cancer 3/3/2015 7:01:22 AM
12345678910...
//-->